These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23814152)

  • 61. Differing perspectives on diagnostic proposals for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
    Dimsdale JE; Levenson J; Sharpe M
    J Psychosom Res; 2011 Jun; 70(6):496-7. PubMed ID: 21624571
    [No Abstract]   [Full Text] [Related]  

  • 62. Proteomic biomarkers for psychiatric disorders: a progress update.
    Martins-de-Souza D; Turck CW
    Biomark Med; 2012 Apr; 6(2):189-92. PubMed ID: 22448792
    [No Abstract]   [Full Text] [Related]  

  • 63. Standards for DSM-5 reliability.
    Spitzer RL; Williams JB; Endicott J
    Am J Psychiatry; 2012 May; 169(5):537; author reply 537-8. PubMed ID: 22549210
    [No Abstract]   [Full Text] [Related]  

  • 64. The attenuated psychosis syndrome in DSM-5.
    Simon AE; Riecher-Rössler A; Lang UE; Borgwardt S
    Schizophr Res; 2013 Dec; 151(1-3):295. PubMed ID: 24094680
    [No Abstract]   [Full Text] [Related]  

  • 65. Misunderstandings about attenuated psychosis syndrome in the DSM-5.
    Carpenter WT; Regier D; Tandon R
    Schizophr Res; 2014 Jan; 152(1):303. PubMed ID: 24331869
    [No Abstract]   [Full Text] [Related]  

  • 66. Grading of insight in the era of DSM 5- exploring the ambiguity.
    Pal A
    Asian J Psychiatr; 2019 Feb; 40():1-2. PubMed ID: 30658241
    [No Abstract]   [Full Text] [Related]  

  • 67. Using the WHODAS 2.0 to assess functional disability associated with DSM-5 mental disorders.
    Konecky B; Meyer EC; Marx BP; Kimbrel NA; Morissette SB
    Am J Psychiatry; 2014 Aug; 171(8):818-20. PubMed ID: 25082488
    [No Abstract]   [Full Text] [Related]  

  • 68. On the way to DSM-V.
    Hebebrand J; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2011 Feb; 20(2):57-60. PubMed ID: 21267613
    [No Abstract]   [Full Text] [Related]  

  • 69. DSM revision surrounded by controversy.
    Collier R
    CMAJ; 2010 Jan; 182(1):16-7. PubMed ID: 19920166
    [No Abstract]   [Full Text] [Related]  

  • 70. [Have we moved on to the DSM-5? A debate with clinical, social and financial implications].
    Leon-Sanromà M; Mínguez J; Cerecedo MJ; Téllez J
    Aten Primaria; 2014 Jan; 46(1):4-5. PubMed ID: 24355582
    [No Abstract]   [Full Text] [Related]  

  • 71. Potential Lessons for DSM From Contemporary Philosophy of Science.
    Kendler KS
    JAMA Psychiatry; 2022 Feb; 79(2):99-100. PubMed ID: 34878514
    [No Abstract]   [Full Text] [Related]  

  • 72. Diagnostic and statistical manual of mental disorders.
    Mittal VA; Walker EF
    Psychiatry Res; 2011 Aug; 189(1):158-9. PubMed ID: 21741095
    [No Abstract]   [Full Text] [Related]  

  • 73. Current research on biological markers.
    Kasper S
    World J Biol Psychiatry; 2014 Jan; 15(1):1. PubMed ID: 24410178
    [No Abstract]   [Full Text] [Related]  

  • 74. Defining disorders of the mind.
    McLaren N
    Med J Aust; 2010 Jun; 192(11):671. PubMed ID: 20528728
    [No Abstract]   [Full Text] [Related]  

  • 75. On the translation of DSM-5 into Turkish.
    Öztürk MO
    Turk Psikiyatri Derg; 2014; 25(1):69-71. PubMed ID: 24738155
    [No Abstract]   [Full Text] [Related]  

  • 76. [Editorial: About the French translation of the DSM-5].
    Masson M
    Encephale; 2015 Sep; 41(4):285-6. PubMed ID: 26341537
    [No Abstract]   [Full Text] [Related]  

  • 77. Context matters: communicating the need for biomarkers for mental illnesses to the general public.
    Carew M; Dean B; Bush AI; Cooke I
    Australas Psychiatry; 2016 Oct; 24(5):512. PubMed ID: 27683861
    [No Abstract]   [Full Text] [Related]  

  • 78. The endless and frequently fallacious quest to identify biomarkers of mental disorders.
    Balon R
    Ann Clin Psychiatry; 2020 May; 32(2):77-79. PubMed ID: 32343280
    [No Abstract]   [Full Text] [Related]  

  • 79. Unconvincing evidence for peripheral biomarkers in major mental disorders.
    Munkholm K
    Transl Psychiatry; 2021 Apr; 11(1):237. PubMed ID: 33888683
    [No Abstract]   [Full Text] [Related]  

  • 80. Antipsychotic treatment and mortality in schizophrenia.
    Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Björkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
    Schizophr Bull; 2015 May; 41(3):656-63. PubMed ID: 25422511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.